Maria Molinelli, | |
45 Meriden Ave, Southington, CT 06489-3214 | |
(860) 621-9559 | |
Not Available |
Full Name | Maria Molinelli |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation |
Location | 45 Meriden Ave, Southington, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891443040 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 004005 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Maria Molinelli, 136 Sheffield Pl, Southington, CT 06489-1370 Ph: (860) 839-2589 | Maria Molinelli, 45 Meriden Ave, Southington, CT 06489-3214 Ph: (860) 621-9559 |
News Archive
Cancer tumors manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by the University of Oxford.
Take a millionth of a human brain and squeeze it into a special chamber the size of a mustard seed. Link it to a second chamber filled with cerebral spinal fluid and thread both of them with artificial blood vessels in order to create a microenvironment that makes the neurons and other brain cells behave as if they were in a living brain. Then surround the chambers with a battery of sensors that monitor how the cells respond when exposed to minute quantities of dietary toxins, disease organisms or new drugs under development.
Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.
e-Therapeutics plc announces that it has started a randomised double-blind controlled phase IIb trial of ETS6103 in major depressive disorder.
This Lancet editorial notes the release of an Institute of Medicine (IOM) report commissioned by the Food and Drug Administration (FDA) that gathers information on "the global threat of falsified or substandard drugs" and provides recommendations "to mitigate this public health problem."
› Verified 1 days ago
Jessica Bocek, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 45 Evergreen Ln, Southington, CT 06489 Phone: 860-919-6353 | |
Matthew Patrick Raymond, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 340 N Main St, Southington, CT 06489 Phone: 860-628-3111 Fax: 860-628-3119 |